Agile therapeutics announces preliminary expectations for first quarter 2023

Princeton, n.j., april 28, 2023 (globe newswire) -- agile therapeutics, inc. (nasdaq: agrx), a women's healthcare company, today announced preliminary expectations for first quarter 2023 twirla® demand, net revenue and operating expenses.

AGRX Ratings Summary

AGRX Quant Ranking